Angiotensin-(1-7) Decreases Cell Growth and Angiogenesis of Human Nasopharyngeal Carcinoma Xenografts

Mol Cancer Ther. 2016 Jan;15(1):37-47. doi: 10.1158/1535-7163.MCT-14-0981. Epub 2015 Dec 15.

Abstract

Angiotensin-(1-7) [Ang-(1-7)] is an endogenous, heptapeptide hormone acting through the Mas receptor (MasR), with antiproliferative and antiangiogenic properties. Recent studies have shown that Ang-(1-7) has an antiproliferative action on lung adenocarcinoma cells and prostate cancer cells. In this study, we report that MasR levels were significantly upregulated in nasopharyngeal carcinoma (NPC) specimens and NPC cell lines. Viral vector-mediated expression of Ang-(1-7) dramatically suppressed NPC cell proliferation and migration in vitro. These effects were completely blocked by the specific Ang-(1-7) receptor antagonist A-779, suggesting that they are mediated by the Ang-(1-7) receptor Mas. In this study, Ang-(1-7) not only caused a significant reduction in the growth of human nasopharyngeal xenografts, but also markedly decreased vessel density, suggesting that the heptapeptide inhibits angiogenesis to reduce tumor size. Mechanistic investigations revealed that Ang-(1-7) inhibited the expression of the proangiogenic factors VEGF and PlGF. Taken together, the data suggest that upregulation of MasR could be used as a diagnostic marker of NPC and Ang-(1-7) may be a novel therapeutic agent for nasopharyngeal cancer therapy because it exerts significant antiangiogenic activity.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Angiogenesis Inhibitors / pharmacology*
  • Angiotensin I / pharmacology*
  • Animals
  • Carcinoma
  • Cell Line, Tumor
  • Cell Movement / drug effects
  • Cell Proliferation
  • Disease Models, Animal
  • Female
  • Humans
  • Hypoxia-Inducible Factor 1, alpha Subunit / metabolism
  • MAP Kinase Signaling System / drug effects
  • Membrane Proteins / metabolism
  • Mice
  • Nasopharyngeal Carcinoma
  • Nasopharyngeal Neoplasms / drug therapy
  • Nasopharyngeal Neoplasms / pathology*
  • Neovascularization, Pathologic / drug therapy
  • Peptide Fragments / pharmacology*
  • Proto-Oncogene Mas
  • Receptors, Vascular Endothelial Growth Factor / metabolism
  • Tumor Burden / drug effects
  • Vascular Endothelial Growth Factor A / metabolism
  • Xenograft Model Antitumor Assays

Substances

  • Angiogenesis Inhibitors
  • Hypoxia-Inducible Factor 1, alpha Subunit
  • MAS1 protein, human
  • Membrane Proteins
  • PIGF protein, human
  • Peptide Fragments
  • Proto-Oncogene Mas
  • Vascular Endothelial Growth Factor A
  • Angiotensin I
  • Receptors, Vascular Endothelial Growth Factor
  • angiotensin I (1-7)